The US Food and Drug Administration (FDA) and the European Commission (EC) have made a breakthrough in allowing the sale of raw molluscan shellfish from the US and EU to consumers in the other region, marking the first time since 2010 that such imports will be permitted. The FDA's equivalence determination, published in the Federal Register, signifies that the EU's food safety control measures for raw bivalve molluscan shellfish, coupled with additional measures for export to the US, meet the same sanitary protection standards as the US. The agreement initially allows firms in Washington and Massachusetts to export to the EU, with other states to potentially follow. The FDA plans to evaluate and recognize other EU Member States as equivalent in the future, following a positive response to a proposed determination in 2018. A webinar for the shellfish industry is scheduled for October 2020 to provide more information.